U.S. markets closed

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.0100+0.3900 (+14.89%)
At close: 04:00PM EDT
3.0300 +0.02 (+0.66%)
After hours: 06:05PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.6200
Bid3.0100 x 900
Ask3.0600 x 100
Day's Range2.5600 - 3.1000
52 Week Range2.5300 - 9.0800
Avg. Volume1,498,103
Market Cap436.727M
Beta (5Y Monthly)1.24
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for ADPT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Adaptive Biotechnologies Corpor
    VIR: Raising target price to $10.00VIR BIOTECHNOLOGY INC has an Investment Rating of HOLD; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • InvestorPlace

    The 7 Best Penny Stocks to Buy in Q2 2024

    This month in March is a great time to pick up shares in these best penny stocks to buy. I chose the companies due to their strong fundamentals and potential for significant upside. Investing in penny stocks can provide the opportunity for substantial returns, as these lower-priced shares have more room for capital appreciation compared to large-cap stocks. However, penny stocks also come with increased volatility and risk, so it’s important to thoroughly research each company. With major indice

  • Fortune

    Team behind popular Falcon AI models unveils new startup with $20 million in funding aimed at helping companies tailor LLMs for business

    Index Ventures is leading the funding round for Adaptive, whose tech makes it easier for company's to tune AI models.

  • Insider Monkey

    Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript

    Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript February 14, 2024 Adaptive Biotechnologies Corporation beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.32. Adaptive Biotechnologies Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]